SecBot SecBot
8-K ·Filed May 4, 2026

ECVT

Ecovyst Inc.
BULLISH
Impact 7/10
Horizonmonths Processed5mo ago SEC0001193125-26-202584
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight ▲ Bullish

Traders should monitor for closing conditions satisfaction and any financing announcements. The deal is strategically accretive and moderately sized, but integration risks remain. Watch for potential synergies disclosure in future filings.

DirectionBullish
Confidencemedium
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
ECVT ▼ -14.80% at T+60d
LONG call ✗ call lost -14.80% · α vs SPY -16.66% · entry $14.12 → $12.03
Entry = T+0 close
May 4, 2026
via day close
T+1d
+4.32%
call +4.32% · α +3.52%
$14.73
settled 6mo ago
T+5d
+2.12%
call +2.12% · α -0.81%
$14.42
settled 6mo ago
T+20d
-7.72%
call -7.72% · α -13.36%
$13.03
settled 5mo ago
T+60d
-14.80%
call -14.80% · α -16.66%
$12.03
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Ecovyst Inc. has agreed to acquire INEOS Calabrian Holdings Corp. and INEOS Calabrian Corporation Canada, Inc. for a base purchase price of $190 million, subject to customary adjustments. The deal expands Ecovyst's portfolio into on-purpose SO2 and derivatives production and is expected to close in Q2 2026.

Key Financial Metrics

Deal Value
$190.0M
Deal Type
acquisition

Key Facts

  • Purchase price of $190 million (base), subject to customary cash and working capital adjustments.
  • Acquisition of on-purpose SO2 and derivatives business (sodium metabisulphite, sodium bisulphite, sodium thiosulphate).
  • Expected closing in Q2 2026 (Scheduled Completion Date June 30, 2026).
  • Conditions include no material adverse change and no material breach of fundamental warranties.
  • Ecovyst is procuring a warranty and indemnity insurance policy for recourse.

Financial Impact

$190 million base purchase price (approximately 12% of Ecovyst's market cap)

revenueoperating income

Risk Factors

  • Failure to satisfy closing conditions (no material adverse change, warranty condition).
  • Regulatory approvals may delay or prevent closing.
  • Integration challenges and execution risk.
  • Debt financing may increase leverage.

Market Snapshot

Exchange
NYSE
Sector
Chemicals & Allied Products
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Materials & Mining

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-202584
Document: d311325d8k.htm0001193125-26-202584
Document: 0001193125-26-202584-index-headers.html0001193125-26-202584
Document: 0001193125-26-202584-index.html0001193125-26-202584
Document: 0001193125-26-202584.txt0001193125-26-202584
7 reports for ECVT
Performance horizon
33% Hit rate @ T+1 1 of 3 directional calls Went positive at some point 2 of 3 best @ T+60▲ +16.42%Feb 26, 2026
Filters
Rows
Reports for ECVT — sortable, filterable
TypeNow
Sep 14, 2026
6w ago
Insider Buy
BULLISH ★ 4/10
$10.54 $10.88▲ +3.23%▲ +3.67%$9.97 (−5.41%)
Aug 5, 2026
11w ago
Press Release
MIXED ★ 6/10
$11.45 $11.00▼ −3.93%▼ −3.77%$9.97 (−12.93%)
Jun 30, 2026
17w ago
8-K
NEUTRAL ★ 5/10
$12.00 $11.83▼ −1.42%▼ −1.29%$9.97 (−16.92%)
Jun 11, 2026
19w ago
Institutional Cluster
MIXED ★ 4/10
$12.94 $13.09▲ +1.16%▲ +0.62%$9.97 (−22.95%)
May 5, 2026
25w ago
8-K
BULLISH ★ 8/10
$14.73 $14.68▼ −0.34%▼ −1.72%$9.97 (−32.32%)
May 4, 2026
25w ago
8-K
BULLISH ★ 7/10
$14.12 $14.73▲ +4.32%▲ +3.52%$9.97 (−29.39%)
Feb 26, 2026
34w ago
8-K
BULLISH ★ 8/10
$11.45 $11.27▼ −1.57%▼ −1.12%$9.97 (−12.93%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 6h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026